Ontology highlight
ABSTRACT:
SUBMITTER: He J
PROVIDER: S-EPMC6204834 | biostudies-other | 2018 Oct
REPOSITORIES: biostudies-other
He Jintang J Yu Shang-Fan SF Yee Sharon S Kaur Surinder S Xu Keyang K
mAbs 20180726 7
Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. T-DM1 is composed of the humanized monoclonal antibody trastuzumab connected to a maytansine derivative cytotoxic drug, via a nonreducible thioether linker at random lysine residues, and therefore has a very complex molecular structure. It was anticipated that T-DM1 undergoes biotransformations in circulation. However, there was limited knowledge on these structural changes due ...[more]